Alvimedica Products are Entrusted to Optimalnoe Zdorovie in Russia

Hundred percent Turkish founded, Alvimedica continues its successful endeavors. Alvimedica, which opened its manufacturing facility in Catalca in 2009, has had its stent called Coracto recognized as the most successful drug eluting stent by two worldwide known specialists: Prof. Renu Virmani and Prof. Nicolaus Reifart, and have entrusted the distribution of its products to Optimalnoe Zdorovie in Russia. As a result of the agreement signed, Optimalnoe Zdorovie will be distributing Alvimedica products in Russia for the next three years.

Optimal Zdorovie –which was founded in 1999 and started its operations in 2006- is working with the Russian government. The company is issuing invitations for tenders and administrating bidding sessions on behalf of the government. Amongst its procurement partners there are also well-known companies like Johnson & Johnson and Abbott. The company is operating in the HIV drugs’ market and achieved a 40 percent market share in 2010. In 2006 - the year Optimalnoe Zdorovie started operating- the company’s total sales amount was $20 mio. In 2009 the company increased this number to $100 mio, and anticipates sales figures for 2010 to rise to as much as $120 mio.

To watch the video which was shot during the agreement meeting between Alvimedica and Optimalnoe Zdorovie in Russia please click here.